Literature DB >> 16231623

Evaluation of a preprimed microporous hollow-fiber membrane for rapid response neonatal extracorporeal membrane oxygenation.

Richard Walczak1, D Scott Lawson, David Kaemmer, Craig McRobb, Patty McDermott, Greg Smigla, Ian Shearer, Andrew Lodge, James Jaggers.   

Abstract

Delays in initiating extracorporeal membrane oxygenation (ECMO) in the critically ill pediatric patient may lead to adverse outcomes. Maintaining a primed ECMO circuit can considerably reduce the initiation time. The predominant concerns precluding this practice are a decrease in oxygenator efficiency due to the saturation of microporous hollow fibers and compromised sterility when the oxygenator has been primed for 30 days. For institutions using a hollow-fiber oxygenator for ECMO, there are no data reporting pre-primed hollow-fiber oxygenator viability. This study reports the efficiency of oxygen transfer and the sterility of the Carmeda Minimax Plus (Medtronic, Inc, Minneapolis, MN) oxygenator after being crystalloid primed for 30 days. A total of 10 Minimax Plus oxygenators were tested for oxygen transfer in a laboratory setting utilizing fresh whole bovine blood. The control group (n =5) were tested immediately after priming. The test group (n =5) were oxygenators primed for 30 days with crystalloid solution and left stagnant until tested. Prior to testing, all oxygenators were circulated for 5 min and samples drawn to test for circuit sterility. Venous inlet saturations were manipulated to achieve three levels of testing: venous saturation (SvO2) of 55% for an oxygen challenge, SvO2 of 65% to comply with AAMI standards, and SvO2 of 75% to assess oxygen transfer rates and peak PaO2 achievement. Blood flow for all tests was maintained at 2 L/min with 1:1 blood to gas flow ratio and 100% FiO2. Samples were drawn pre- and postoxygenator at 1- and 6-hour time intervals to compute actual oxygen transfer values. All cultures from the test group priming solution produced no microbial growth after 30 days of stagnant prime. Average oxygen transfer values (ml/O2/min) for the control group after 1 hour of continuous use were 130.1+/-15.5 (@ 55% SvO2), 113.7+/-10.4 (@ 65% SvO2), 97.7+/-8.9 (@ 75% SvO2). After 6 hours, the average transfer values increased to 134.2+/-13.2 (@ 55% SvO2), 118.76+/-6.6 (@ 65% SvO2) and 98.9+/-8.3 (@ 75% SvO2). The average oxygen transfer values after 1 hour for oxygenators primed for 30 days were 114.9+/-10.0 (@ 55% SvO2), 112.4+/-8.2 (@ 65% SvO2) and 89.6+/-16.0 (@ 75% SvO2). After 6 hours of use, the average transfer values all decreased to 111.4+/-2.1 (@ 55% SvO2, p <0.05 versus control), 104.0+/-5.6 (@ 65% SvO2, p <0.05 versus control) and 88.4+/-3.2 (@ 75% SvO2, p <0.05 versus control). In conclusion, there was a decrease in the average oxygen transfer values for the test group after 6 hours versus the control. The modest loss of oxygen transfer ability observed can be considered acceptable due to the amount of surface area of the Minimax Plus oxygenator when used on a neonate, making it feasible to adopt the practice of prepriming the Minimax oxygenator for neonatal ECMO.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16231623     DOI: 10.1191/0267659105pf819oa

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  5 in total

1.  Retrospective analysis comparing hollow fiber and silicone membrane oxygenators for neonates on ECMO.

Authors:  Brian Mejak; Carmen Giacomuzzi; Eileen Heller; Xiaomang You; Ross Ungerleider; Irving Shen
Journal:  J Extra Corpor Technol       Date:  2007-06

2.  Sterility Duration of Preprimed Extracorporeal Membrane Oxygenation Circuits.

Authors:  Vi Ean Tan; Alan T Evangelista; Dominick M Carella; Daniel Marino; Wayne S Moore; Nadji Gilliam; Arun Chopra; Jeffrey J Cies
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Jul-Aug

3.  Position paper for the organization of ECMO programs for cardiac failure in adults.

Authors:  Darryl Abrams; A Reshad Garan; Akram Abdelbary; Matthew Bacchetta; Robert H Bartlett; James Beck; Jan Belohlavek; Yih-Sharng Chen; Eddy Fan; Niall D Ferguson; Jo-Anne Fowles; John Fraser; Michelle Gong; Ibrahim F Hassan; Carol Hodgson; Xiaotong Hou; Katarzyna Hryniewicz; Shingo Ichiba; William A Jakobleff; Roberto Lorusso; Graeme MacLaren; Shay McGuinness; Thomas Mueller; Pauline K Park; Giles Peek; Vin Pellegrino; Susanna Price; Erika B Rosenzweig; Tetsuya Sakamoto; Leonardo Salazar; Matthieu Schmidt; Arthur S Slutsky; Christian Spaulding; Hiroo Takayama; Koji Takeda; Alain Vuylsteke; Alain Combes; Daniel Brodie
Journal:  Intensive Care Med       Date:  2018-02-15       Impact factor: 17.440

4.  Outcomes before and after implementation of a pediatric rapid-response extracorporeal membrane oxygenation program.

Authors:  Joseph W Turek; Nicholas D Andersen; D Scott Lawson; Desiree Bonadonna; Ryan S Turley; Michelle A Peters; James Jaggers; Andrew J Lodge
Journal:  Ann Thorac Surg       Date:  2013-03-15       Impact factor: 4.330

5.  Extracorporeal membrane oxygenation circuitry.

Authors:  Laurance Lequier; Stephen B Horton; D Michael McMullan; Robert H Bartlett
Journal:  Pediatr Crit Care Med       Date:  2013-06       Impact factor: 3.624

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.